Type of Lymph Node Involvement Influences Survival Rates in T1N1M0 Non-small Cell Lung Carcinoma: Lymph Node Involvement by Direct Extension Compared With Lobar and Hilar Node Metastases

Chest

Volumn 110, Issue 6, 1996, Pages 1469-1473

  Van Velzen, Edwin ^a   Snijder, Repke J ^a   De La Rivière, Aart Brutel ^a   Elbers, Hans J J ^a   Van Den Bosch, Jules M M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Direct extension; T1N1M0 non small cell carcinoma; Type of lymph node involvement

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030448060     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.6.1469     Document Type: Article

References (22)

1. Mountain CF. The new international system for staging lung cancer. Chest 1986; 89:225s-32s
2. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-47
3. Yano T, Yokoyama H, Inoue T, et al. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 1994; 107:1398-1402
4. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76:832-39
5. Martini N, Beattie EJ Jr. Results of surgical treatment in stage II lung cancer. J Thorac Cardiovasc Surg 1977; 74:499-505
6. Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage II lung cancer. J Thorac Cardiovasc Surg 1981; 82:70-6
7. Clifton EE. The criteria for operability and resectability in lung cancer. JAMA 1966; 195:1031-32
8. van Houtte P, Rocmans P, Smets P, et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of a curative design. Int J Radiat Oncol Biol Phvs 1980; 6:983-86
9. Murren JR, Buzaid AC. Chemotherapy and radiation for the treatment of non-small-cell lung cancer: a critical review. Lung Cancer 1993; 14:161-71
10. Mountain CF. Lung cancer staging classification. Clin Chest Med 1993; 14:43-53
11. Belcher JR, Anderson R. Surgical treatment of carcinoma of the bronchus. BMJ 1965; 1:948-54
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
13. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J Stat Soc (series A) 1972; 135:185-98
14. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34:187-220
15. Martini N, Flehinger BJ, Nagasaki F, et al. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1983; 86:646-53
16. Immerman SC, Vanecko RM, Fry WA, et al. Site of recurrence in patients with stages II and II carcinoma of the lung resected for cure. Ann Thorac Surg 1981; 32:23-6
17. Maggi G, Casadio C, Mancuso M, et al. Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases, Int Surg 1990; 75:17-21
18. Martini N, Burt ME, Bains MS, et al. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Snrg 1992; 54:460-66
19. Matthews MJ, Kanhouwa S, Pickren J, et al. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. Cancer Chemother Rep 1973; 4:63-7
20. Ferguson MK, Little AG, Golomb HM, et al. The role of adjuvant therapy after resection of T1N1M0 and T2N2M0 non-small cell lung cancer J Thorac Cardiovasc Surg 1986; 91:344-49
21. Holmes EC, Hill LD, Gail M. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. Ann Surg 1985; 202:335-40
22. Newman SB, DeMeester TR, Golomb HM, et al. Treatment of modified stage II (T1N1M0, T2N1M0) non-small cell bronchogenic carcinoma. J Thorac Cardiovasc Surg 1983; 86:180-85